Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are between 18 and 65 years of age
- People who have been diagnosed with cirrhosis (severe scarring of the liver), confirmed through clinical assessment, blood tests, tissue samples (when available), and ultrasound imaging
- People with cirrhosis who are seriously ill and have been admitted to a Liver Intensive Care Unit
Who may not be able to join:
- People who are older than 65 years
- People who have long-term kidney disease
- People who are pregnant or who have developed heart weakness related to pregnancy or childbirth
- People who have a heart valve condition
- People who have a condition called sick sinus syndrome, or who have a pacemaker fitted
- People who have had a procedure called a TIPS (a shunt placed inside the liver to manage blood flow and pressure)
- People who have liver cancer (hepatocellular carcinoma)
- People whose blood count is too low at the time of assessment — specifically, women with a haemoglobin level below 8 g/dL or men with a haemoglobin level below 9 g/dL (confirm with trial site if unsure what this means for a specific situation)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 01722754777
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Determine the prevalence of cirrhotic cardiomyopathy in critically ill patients with cirrhosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.